Caricamento Eventi

« Tutti gli Eventi

NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER: MORE THAN JUST DOWNSIZING

18 settembre - 25 settembre

PROGRAM

18 September 2020 | 1° Module

09:00/09:30 Opening ceremony and introduction to the Meeting. (Authotities welcome)

09:30/10:00 Main Lecture: What have we learned so far? From Halsted to Fisher. P.F. Conte (Padua)

Chairmen: M. Guido (Padua), E. Orvieto (Rovigo)

10.00/10:15 NACT in the non-luminal HER2 positive breast cancer. L. Laurino (Mestre)

10.15/10:30 Triple-Negative breast cancer: who should receive neoadjuvant chemotherapy? Do TILs play any role? M. Cacciatore (Treviso)

10:30/10:45 Does NACT in breast cancer improve overall survival? R. Babare (Treviso)

10.45/11.00 Question time

Chairmen: G. Morana (Treviso), S. Montemezzi (Verona)

11:00/11:15 What is the best way to assess the response to NACT? L. Martincich (Asti)

11:15/11:30 Diagnostic assessment of extent of disease in axilla before, during, and after NACT. C. Weiss (Treviso)

11:30/11:40 Question time

11:40/12:00 The correct treatment of the surgical specimen: from the needle to the microscope. A. Ferrario (Monza), A. Segnalini (Monza)


25 September 2020 | 2° Module

09:00/09:20 Opening ceremony and introduction to the Meeting. (Authotities welcome)

09:20/09:40 Expert’s point of view: Surgical management of patients undergoing NACT. C. Mariotti (Ancona)

Chairmen: G.P. Pollini (Verona), G. Meneghini (Arzignano), G. Papaccio (Mestre)

09:40/09:55 Is breast conservative surgery feasible after NACT? C. Cedolini (Udine)

09:55/10:10 Management of axilla after NACT: is BLS dependable? C. Rizzetto (Treviso)

10:10/10:25 Nipple-sparing mastectomy after NACT: is there any controindication? G. Berna (Treviso)

10:25/10:40 Does NACT increase complication rate in breast surgery? T. Saibene (Padua)

10:40/10:55 Pathological complete response and long-term clinical benefit in breast cancer. G. Luridiana (Cagliari)

10:55/11:05 Question time

Chairmen: A. Gava (Treviso), A. Favaretto (Treviso)

11:05/11:20 Radiation therapy after surgery in patients undergoing NACT. M. Cesaro (Treviso)

11:20/12:35 NACT, surgery and then, what else? V. Guarneri (Padua)

12:35/12:50 Back to the future: can breast biopsy after NACT accurately predict presence of residual burden disease and eliminate surgery? M. Roncella (Pisa)

12:50/12:00 Conclusions. P. Burelli (Treviso)


GENERAL INFORMATIONS

SCIENTIFIC BOARD
Dr Paolo Burelli
Dr Christian Rizzetto

SCIENTIFIC SECRETARIAT
Dr.ssa Franca Callegari
Dr.ssa Barbara Gnocato

CME CREDITS
Credits for Continuing Medical Education for Psysician and Nurse.

RESERVATIONS
Congress reservation is required and free of charge.

ATTACHMENTS
Program FAD BREAST CANCER.pdf

CON LA SPONSORIZZAZIONE NON CONDIZIONANTE DI


Prenotati compilando il modulo sottostante.
Tutti i campi sono obbligatori.
Importante: indicare la mail corretta.



Ho letto l’INFORMATIVA PRIVACY ai sensi del regolamento UE 2016/679
all’invio, da parte del Titolare, di newsletter, inviti ad eventi congressuali per la FORMAZIONE IN MEDICINA o convegni rivolti alla professione, comunicazioni e/o materiale informativo relativi a servizi o attività di interesse dell’Individuo, anche con modalità automatizzate, sia via e-mail, sia via posta cartacea e/o telefono e/o via sistemi di instant messaging.

Dettagli

Inizio:
18 settembre
Fine:
25 settembre
Tag Evento: